Patent ID: 11912743
Assignee: NOUSCOM AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The expression vector of claim 2, wherein the expression vector is selected from the group consisting of: an alphavirus vector, a venezuelan equine encephalitis (VEE) virus vector, a sindbis (SIN) virus vector, a semliki forest virus (SFV) virus vector, a simian or human cytomegalovirus (CMV) vector, a Lymphocyte choriomeningitis virus (LCMV) vector, a retroviral vector, a lentiviral vector, an adenoviral vector, an adeno-associated virus vector, a poxvirus vector, a vaccinia virus vector or a modified vaccinia ankara (MVA) vector.